EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell‐Cycle Control and Tumor Microenvironment Reprogramming

Robert Kubina iD, Maria-Laura Morawiec iD, Ilona Nowak, Robert Sarna, Kamil Krzykawski, Agata Kabała-Dzik, Arkadiusz Dziedzic iD, Aleksandra Mielczarek-Palacz, Javad Sharifi-Rad iD, William N Setzer iD, Daniela Calina iD

Cell Biology International · 2026-06 · 50 (6)

DOI: 10.1002/cbin.70166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology International, online erschienen am 19.05.2026. Verfasst von Robert Kubina und 10 weiteren Autor:innen. Beteiligte Einrichtung: Silesia LabMed: Centre for Research and Implementation, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Triterpenes, Tumor Microenvironment, Lanosterol, Neoplasms. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganodermanontriol (GDNT), a lanostane‐type triterpenoid derived from Ganoderma lucidum , exhibits multiple pharmacological properties, with emerging evidence supporting its anticancer potential. Despite the long‐standing medicinal use of G. lucidum , the specific role and mechanisms of GDNT in oncology require further clarification. This review presents a comprehensive analysis of preclinical studies investigating the anticancer activity of GDNT in various cancer types, including nasopharyngeal, hepatocellular, gastric, colorectal, breast, prostate, and lung malignancies. Relevant experimental literature was identified and evaluated, with emphasis on in vitro and in vivo models exploring the molecular mechanisms of GDNT. Key pathways implicated in its activity include NF‐κB/MAPK, TLR4/MyD88, Wnt/β‐catenin, CES2/MPA metabolism, and androgen receptor signaling. Experimental findings demonstrate that GDNT induces apoptosis, arrests cell cycle progression, and inhibits tumor cell proliferation, migration, and invasion. It also modulates the tumor microenvironment through suppression of M2 macrophage polarization and pro‐tumor cytokine expression. Semi‐synthetic analogs of GDNT display improved cytotoxicity and selectivity, highlighting the relevance of structural optimization in enhancing bioactivity. Although clinical data on GDNT are currently lacking, studies involving G. lucidum extracts suggest potential benefits as supportive agents in oncologic care, particularly in immune modulation and enhancement of chemotherapeutic efficacy. Ongoing research into GDNT's pharmacological profile, including its derivatives, may support its development as a novel candidate in cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesTumor MicroenvironmentLanosterolNeoplasmsCell Cycle CheckpointsHumansSignal TransductionAnimalsApoptosisReishiAntineoplastic AgentsCell Proliferation

Stichwörter der Autor:innen

Ganoderma lucidumapoptosiscancer therapyganodermanontriolnatural productstriterpenoids

Substanzen

TriterpenesLanosterolganodermanontriolAntineoplastic Agents

Autor:innen und Institutionen

  • Silesia LabMed: Centre for Research and Implementation, Medical University of Silesia, Katowice, Poland.
  • Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland.
  • Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
  • Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland.
  • Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Katowice, Poland.
  • Universidad Espíritu Santo, Samborondón, Ecuador.

ORCID-Profile: Robert Kubina, Maria-Laura Morawiec, Arkadiusz Dziedzic, Javad Sharifi-Rad, William N Setzer, Daniela Calina

Zitieren

APA

Kubina, R., Morawiec, M. L., Nowak, I., Sarna, R., Krzykawski, K., Kabała-Dzik, A., Dziedzic, A., Mielczarek-Palacz, A., Sharifi-Rad, J., Setzer, W. N., & Calina, D. (2026). Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell‐Cycle Control and Tumor Microenvironment Reprogramming. Cell Biology International, 50(6). https://doi.org/10.1002/cbin.70166

Vancouver

Kubina R, Morawiec ML, Nowak I, Sarna R, Krzykawski K, Kabała-Dzik A, et al. Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell‐Cycle Control and Tumor Microenvironment Reprogramming. Cell Biology International. 2026;50(6). doi:10.1002/cbin.70166

BibTeX
@article{Kubina2026,
  author = {Kubina, Robert and Morawiec, Maria-Laura and Nowak, Ilona and Sarna, Robert and Krzykawski, Kamil and Kabała-Dzik, Agata and Dziedzic, Arkadiusz and Mielczarek-Palacz, Aleksandra and Sharifi-Rad, Javad and Setzer, William N and Calina, Daniela},
  title = {Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell‐Cycle Control and Tumor Microenvironment Reprogramming},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {6},
  doi = {10.1002/cbin.70166}
}
Kostenlos starten →